Mr Cuevas said: “Hal comes to Interventional Spine with a broad financial background that includes more than 20 years of public accounting experience with Coopers & Lybrand (now part of PricewaterhouseCoopers), and both public and private company financial management responsibility as CFO, most recently in this capacity with Micro Therapeutics, (now a division of ev3). In addition, he brings leadership experience in human resources and information technology, diversified fund raising and Sarbanes-Oxley compliance.”